IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression
- 29 July 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (2) , 470-475
- https://doi.org/10.1016/j.bbrc.2005.05.122
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral OncoproteinsCancer Research, 2004
- Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemopreventionBiochemical Pharmacology, 2004
- Multifaceted roles of cyclooxygenase-2 in lung cancerDrug Resistance Updates, 2004
- Interleukin-10andRelatedCytokines andReceptorsAnnual Review of Immunology, 2004
- Targeting cyclooxygenase-2 in human neoplasiaCancer Cell, 2003
- Lung cancer and cyclooxygenase-2The Annals of Thoracic Surgery, 2003
- The role of COX-2 in angiogenesis and rheumatoid arthritis☆Published by Elsevier ,2003
- Cyclooxygenase 2: a molecular target for cancer prevention and treatmentTrends in Pharmacological Sciences, 2003
- Interleukins 19, 20, and 24 Signal through Two Distinct Receptor ComplexesJournal of Biological Chemistry, 2002
- The Contributions of Cyclooxygenase-2 to Tumor AngiogenesisCancer and Metastasis Reviews, 2000